Answers are grounded in this paper and cite their sources.
STRUCTURED ABSTRACT Objectives New Zealand diagnoses gestational diabetes (GDM) using fasting plasma glucose (FPG) >5.5 mmol/L and/or 2-h post-load glucose (PLG) >9.0 mmol/L. Revised criteria lower the FPG to >5.3 mmol/L and replace the 2-h with 1-h PLG >10.6 mmol/L. Whether these changes affect long-term maternal and child health is unknown. Methods Participants were grouped by their oral glucose tolerance test results as meeting the revised criteria (Additional group), the current criteria (Missed group), both criteria (Both-Criteria group), or neither criteria (Non-GDM group). Results At five years, women in the Additional-Treated and Missed groups had rates of type 2 diabetes/prediabetes higher than the Non-GDM group (36.5% and 29.6% vs 8.7%; P <0.001), although similar to the Both-Criteria group. Women in the Missed group had lower BMI than the Both-Criteria group (27.1 vs. 30.5 kg/m 2 ; P =0.008). More children in the Additional-Treated group than in the Non-GDM group were reported to have poorer health, while lower BMI z-scores were observed in children in the Missed group (0.06 vs 0.54; P =0.024). Participants in the Additional-Untreated group had more maternal cardiometabolic and child neurodevelopmental concerns than the Non-GDM group. After adjustment for maternal ethnicity, most between-group differences were unchanged, although differences in maternal BMI were attenuated and child BMI z-scores more pronounced. Conclusions The revised criteria will identify additional women at risk of future diabetes but exclude another high-risk group currently diagnosed and treated for GDM, potentially compromising their and their children's longer-term health.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: